Prospective experience with a levonorgestrel implant. NorplantLOPEZ, G; RODRIGUIZ, A; RENGIFO, J et al.Contraceptive delivery systems. 1984, Vol 5, Num 4, pp 293-302, issn 0143-6112Article

Antibiotiques par voie sous-cutanée chez la personne âgée = Antibiotics given subcutaneously to elderlyROBELET, Antoine; CARUBA, Thibaut; CORVOL, Aline et al.La Presse médicale (1983). 2009, Vol 38, Num 3, pp 366-376, issn 0755-4982, 11 p.Article

Systemic adrenaline attenuates skin response to antigen and histamineWARREN, J. B; MCCUSKER, M; FULLER, R. W et al.Clinical allergy. 1988, Vol 18, Num 2, pp 197-199, issn 0009-9090Article

Pain perception after subcutaneous injections of media containing different buffersLAURSEN, Torben; HANSEN, Birtha; FISKER, Sanne et al.Basic & clinical pharmacology & toxicology (Print). 2006, Vol 98, Num 2, pp 218-221, issn 1742-7835, 4 p.Article

Therapeutic use of low molecular weight heparins : knowledge to date and their application to therapyHULL, R. D; PINEO, G. F.Seminars in thrombosis and hemostasis. 1994, Vol 20, Num 4, pp 339-344, issn 0094-6176Article

La aguja hipodérmica : concepto, morfología y composición = Hypodermic needle definition, morphology and compositionESTELLER JUYOL, E; MANICH BOU, A; JURADO DANSHEZ, F et al.Ciencia pharmacéutica. 1991, Vol 1, Num 4, pp 251-258, issn 1131-5253Article

Pharmacokinetic observations on ST-1435 administered subcutaneously and intravaginallyLAHTEENMAKI, P. L. A; KURUNMAKI, H; LAHTEENMAKI, P et al.Contraception (Stoneham). 1984, Vol 30, Num 4, pp 381-389, issn 0010-7824Article

Pharmacokinetics of Subcutaneous IgPro20 in Patients with Primary ImmunodeficiencyWASSERMAN, Richard L; MELAMED, Isaac; NELSON, Robert P et al.Clinical pharmacokinetics. 2011, Vol 50, Num 6, pp 405-414, issn 0312-5963, 10 p.Article

Growth hormone treatment without a needle using the Preci-Jet 50 transjectorBAREILLE, P; MACSWINEY, M; ALBANESE, A et al.Archives of disease in childhood. 1997, Vol 76, Num 1, pp 65-67, issn 0003-9888Article

Fibrinolytic response to interferon-α in healthy human subjectsCORSSMIT, E. P. M; LEVI, M; HACK, C. E et al.Thrombosis and haemostasis. 1996, Vol 75, Num 1, pp 113-117, issn 0340-6245Article

Management of late anemia in rhesus hemolytic disease : Use of recombinant human erythropoietin (a pilot study)OVALI, F; SAMANCI, N; DAGOGLU, T et al.Pediatric research. 1996, Vol 39, Num 5, pp 831-834, issn 0031-3998Article

Pharmakokinetik des Buprenorphins bei subkutaner Applikation = Pharmacokinetics of buprenorphine in subcutaneous applicationGRALOW, I; VON HORNSTEIN, W. F; SCHLEYER, E et al.AINS. Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie. 1995, Vol 30, Num 7, pp 412-416, issn 0939-2661Article

Comparison of subcatenously administered soluble insulin and des-(B26-B30)-insulin-B25-amide in rabbit, pig and healthy manHARTMANN, H; MOESUS, E; CREUTZFELDT, W et al.Diabetes research and clinical practice. 1992, Vol 16, Num 3, pp 175-181, issn 0168-8227Article

Subcutaneous heparin theraphy during pregnancy : a need for concern at the time of deliveryANDERSON, D. R; GINSBERG, J. S; BURROWNS, R et al.Thrombosis and haemostasis. 1991, Vol 65, Num 3, pp 248-250, issn 0340-6245Article

Pharmacokinetics of recombinant human erythropoietin in chronic haemodialysis patientsNIELSEN, O. J.Pharmacology & toxicology. 1990, Vol 66, Num 2, pp 83-86, issn 0901-9928Article

The pharmacokinetics, safety and endocrine effects of authentic biosynthetic human growth hormone in normal subjectsHO, K. Y; WEISSBERGER, A. J; STUART, M. C et al.Clinical endocrinology (Oxford. Print). 1989, Vol 30, Num 4, pp 335-345, issn 0300-0664Article

Clinical evaluation of subcutaneously administered DDAVPGHIRARDINI, A; CHISTOLINI, A; TIRINDELLI, M. C et al.Thrombosis research. 1988, Vol 49, Num 3, pp 363-372, issn 0049-3848Article

Administration journalière souscutanée de l'hormone de croissance recombinée chez les enfants déficients en hormone de croissanceTAKANO, K.Yakuri to chiryo. 1988, Vol 16, Num 1, pp 63-73, issn 0386-3603Article

Comparison of pain associated with intradermal and subcutaneous infiltration with various local anesthetic solutionsMORRIS, R; MCKAY, W; MUSHLIN, P et al.Anesthesia and analgesia. 1987, Vol 66, Num 11, pp 1180-1182, issn 0003-2999Article

Inhibitor to factor VIII in a non-haemophilic patient: evaluation of the response to DDAVP and the in vitro kinetics of factor VIII. A case reportCHISTOLINI, A; GHIRARDINI, A; TIRINDELLI, M. C et al.Nouvelle revue française d'hématologie. 1987, Vol 29, Num 4, pp 221-224, issn 0029-4810Article

A morphological study of granulomas induced by subcutaneous injection of leuprorelin acetateWATANABE, T; YAMADA, N; YOSHIDA, Y et al.Journal of cutaneous pathology. 2009, Vol 36, Num 12, pp 1299-1302, issn 0303-6987, 4 p.Article

Subcutaneous Administration of IgGBERGER, Melvin.Immunology and allergy clinics of North America. 2008, Vol 28, Num 4, issn 0889-8561, viii, 779-802 [25 p.]Article

Innovative technique for Norplant® implants removalSHIHATA, A. A; SALZETTI, R. G; SCHNEPPER, F. W et al.Contraception (Stoneham). 1995, Vol 51, Num 2, pp 83-85, issn 0010-7824Article

Return of fertility following discontinuation of Norplant^R-II subdermal implants : ICMR task force on hormonal contraceptionBUCKSHEE, K; CHATTERJEE, P; RAJARAM, P et al.Contraception (Stoneham). 1995, Vol 51, Num 4, pp 237-242, issn 0010-7824Article

The apomorphine test in heroin addictsCASAS, M; GUARDIA, J; PRAT, G et al.Addiction (Abingdon. Print). 1995, Vol 90, Num 6, pp 831-835, issn 0965-2140Article